Top 50 Clinical Trial Platform in LATAM

Sofya is a clinical reasoning platform that utilizes explainable AI to automate routine tasks and support complex clinical decision-making, integrating seamlessly with electronic health records. By enhancing efficiency and personalization in patient care, Sofya addresses the overwhelming administrative burden on healthcare professionals, reducing the time spent on digital paperwork and minimizing medical errors.

Onc.ai develops AI models leveraging oncology real-world data, including imaging, EMR, and genomics, to enhance precision oncology. The company's deep learning imaging AI aims to bring clarity to cancer treatment decision-making for medical oncologists. Initial products focus on predicting clinical outcomes in metastatic lung cancer to support pharmaceutical clinical development.

Siolta Therapeutics develops targeted live biotherapeutics using its Precision Symbiotics Platform™ to create therapeutic microbial consortia that address inflammatory diseases. The company combines clinical data and microbial science to target disease-specific mechanisms, aiming to meet the high unmet medical needs in this area.

Nilo provides a SaaS platform utilizing Artificial Intelligence and automation to enhance the financial results and operational efficiency of healthcare institutions. The solution supports ecosystems, providers, and payers by creating digital patient journeys that improve acquisition, conversion, and retention. Key features include AI agents for risk stratification and care navigation, integrated data management via HL7 FHIR, and performance dashboards for clinical and operational oversight.

Trak is a tele-rehabilitation platform that utilizes AI to provide personalized exercise plans and monitor patient progress in real-time, enhancing adherence to treatment protocols. By enabling healthcare professionals to conduct remote physiotherapy sessions, Trak reduces rehabilitation time and costs while improving patient outcomes.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

Cannect is a digital platform that connects researchers, healthcare institutions, and patients to facilitate access to medical cannabis treatments. By providing a streamlined process for consultations, prescriptions, and product procurement, Cannect addresses the challenges of navigating medical cannabis care in Brazil.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

Axenya provides an integrated corporate health platform combining brokerage, benefits administration, and consulting services with digital operations. The platform leverages advanced analytics and AI for claims management, predictive modeling, and financial reconciliation of health plans. It focuses on proactive clinical navigation and wellness integration to optimize health outcomes and deliver measurable financial ROI for employers.

The startup operates a healthcare management platform that facilitates the scheduling of medical appointments and the management of medication through automated reminders and caregiver coordination. By enabling patients to track medical expenses and refill prescriptions, the platform enhances patient engagement in their health management.

Fullscript is a digital health platform that enables healthcare providers to create personalized supplement plans and order lab tests, enhancing patient engagement and adherence through automated reminders and progress tracking. By integrating with over 30 EHR systems, Fullscript streamlines the workflow for practitioners, allowing them to offer affordable, evidence-based health solutions while maintaining control over patient costs.

Choiz provides a personalized healthcare platform that integrates diagnostic services, medication delivery, and ongoing patient care management. This approach addresses the fragmentation in healthcare by streamlining the patient journey, improving access to necessary treatments and support.

Zeto offers a wireless, dry electrode EEG headset designed for hospital use, eliminating the need for gel application and extensive preparation. This technology enables rapid and efficient brain activity monitoring, improving patient comfort and streamlining clinical workflows.

Keirón Healthtech LATAM provides a cloud‑based SaaS platform that unifies the entire patient journey for hospitals, clinics, surgery centers, and labs in Latin America. Its modular suite includes omnichannel appointment confirmation, real‑time queue management, digital check‑in, automated payment, and clinical budgeting tools that integrate via APIs with existing health‑IT systems, reducing wait times and streamlining financial workflows.

Sade iD is a healthcare platform that facilitates connections between patients, doctors, and healthcare organizations. The platform aims to streamline access to medical services and improve communication within the healthcare ecosystem.

Munai provides an AI-driven clinical intelligence platform that integrates with electronic health records to analyze patient data in real-time. The system automates protocols, generates predictive risk alerts, and offers a 360-degree patient view to support multidisciplinary teams. This capability helps hospitals anticipate clinical deterioration, optimize treatment duration, and improve overall operational efficiency.

The startup operates a health tech platform that assesses employee health risk profiles and predicts future healthcare expenses using data analytics. This enables healthcare practitioners to create tailored action plans, improving individual health outcomes and optimizing healthcare costs for organizations.

Rosebud Biosciences develops targeted therapies for rare pediatric genetic diseases using patient-specific organoid models. The company engineers micropatterned 2.5D organoids from induced pluripotent stem cells that replicate individual genetic mutations for drug screening. This platform enables the high-throughput testing of small molecules, gene therapies, and RNA therapeutics against complex developmental disorders.

DoctorAssistant.ai provides an AI-powered platform that records medical consultations in real time, transcribes the dialogue, and generates structured clinical notes with suggested ICD codes and parsed exam results. The web‑based solution offers customizable SOAP or specialty templates, secure end‑to‑end encryption, and integration with major EHR systems to streamline documentation for physicians and healthcare facilities.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

ViewMind provides a digital assessment platform that uses a head‑mounted display with high‑precision eye‑tracking to capture ocular movement responses to visual stimuli. By converting eye‑movement patterns into objective biomarkers of specific cognitive domains, the system enables early detection, monitoring, and evaluation of neurocognitive health for neurology clinics, memory‑care centers, and CNS drug development programs.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

Voa Health is an AI-driven application that transcribes and processes medical consultations in real-time, generating clinical documentation such as anamneses and prescriptions without the need for manual input. This technology reduces the time clinicians spend on administrative tasks, allowing for more direct patient interaction and improved care quality.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

Asclepius is an AI‑powered clinical assistant that transforms free‑text encounter notes into fully compliant medical records, automatically suggesting ICD‑11 codes and draft prescriptions. It cross‑references the world’s largest biomedical literature database to evaluate treatment options, flag drug interactions, and provide evidence‑based second opinions with full citation support. Integrated into existing workflows, the platform saves clinicians up to three hours per day on documentation while maintaining over 95% citation accuracy.

The startup offers centralized digital health solutions that integrate patient data management and telehealth services to enhance care coordination. This platform addresses inefficiencies in healthcare delivery by providing real-time access to patient information and facilitating remote consultations, ultimately improving patient outcomes and reducing administrative burdens.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

The startup offers a healthcare management and telemedicine platform that facilitates medical appointment scheduling, virtual consultations, and secure transfer of medical documents. By automating patient interactions and appointment processes through a multichannel system, the platform enhances operational efficiency for medical institutions and improves patient experience throughout their healthcare journey.

The startup offers a healthcare management platform that provides real-time health tracking, digital medical records, and preventive health programs for employees. This platform enables organizations to enhance employee well-being and productivity while managing health-related risks effectively.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

Vitazi provides Oculomics-as-a-Service by using AI analytics on retinal scans to detect systemic health risks like diabetes and cardiovascular disease. The platform integrates seamlessly into existing clinical workflows, offering multi-disease detection beyond standard eye disease screening. This enables earlier intervention and supports value-based care metrics for eye care professionals.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

Neri provides a cloud‑based care coordination platform that unifies patients, families, caregivers, and health professionals in a real‑time network. Its AI assistant, accessible via WhatsApp, mobile, and web, interprets images and audio to generate clinical summaries, actionable insights, and reminders, while modular tools (Checks, Scrubs, Pulse) support caregiver routines, mobile clinician case management, and institutional population‑health monitoring.

Doc4Doc provides a 24/7 telemedicine platform connecting healthcare facilities with specialized medical consultants for rapid case review and treatment recommendations. The service enhances diagnostic accuracy and patient management by offering real-time communication and digital transmission of medical information across a broad range of specialties.

Abartys Health has developed a centralized communication platform that integrates healthcare data management for patients, providers, and insurers, enabling secure access to medical records and lab results from any device. This platform addresses the fragmentation in healthcare communication, facilitating streamlined interactions and improving data accessibility across the healthcare ecosystem.

Kintsu is a healthtech platform connecting patients, healthcare professionals, and institutions to improve care coordination. The platform facilitates communication and data sharing to streamline healthcare delivery and enhance patient outcomes.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

OTAWA Health provides a specialized oncology electronic health record (EHR) and clinical decision support (CDS) system designed for cancer care professionals, enabling personalized treatment protocols and streamlined operations across cancer centers. By collecting structured oncology data using FHIR HL7 standards, the platform enhances patient safety and supports real-world evidence studies to improve cancer care outcomes.

MDBee utilizes AI-driven automation to generate pre-encounter patient summaries and automate clinical documentation, enhancing workflow efficiency for healthcare providers. This technology reduces administrative burdens, allowing clinicians to focus more on delivering quality patient care.

Wecancer provides a real-time data analytics platform that monitors cancer patients' health metrics and treatment responses. This technology enables healthcare providers to detect complications early and modify treatment plans, leading to improved patient outcomes.

Teker is a healthtech platform that utilizes a secure telehealth interface to connect patients with specialists across more than ten clinical disciplines. This platform enables timely access to diverse medical expertise, enhancing patient outcomes through efficient consultations.

Hcentrix provides an AI‑driven care management platform that identifies health risks early, prioritizes beneficiaries for timely interventions, and coordinates providers and programs to achieve sustainable health outcomes. The solution offers a live, integrated view of the patient journey, translating data into actionable scenarios for strategic decision‑making, and improves engagement and adherence through rapid, targeted care delivery.

Diag-Nose.io develops the RhinoMAP platform to decode airway biology for respiratory diseases. This platform integrates nasal microsampling, proteomics, and machine learning algorithms to analyze biomarker data. The goal is to enable precision medicine by identifying root causes, leading to faster, more effective treatment selection for patients.

This startup provides personalized medicines through genetic testing and data analysis, enabling microgram-level customization of treatments. By tracking the entire treatment journey, it offers patients affordable, tailored medications and real-time updates on their health status.

Verato offers a healthcare-specific hMDM platform that provides a single source of truth for patient, provider, member, and consumer identities through its patented Referential Matching technology. This solution addresses the challenge of fragmented identity data across healthcare systems, enabling improved clinical interoperability and more accurate patient engagement.

Kinzbio develops phage-based precision antimicrobials to combat antibiotic-resistant infections quickly and effectively. Their platform utilizes AI-driven software and proprietary databases to deliver personalized, pharmaceutical-grade therapies within 5 to 15 days. The company also engineers solutions for infection prevention in clinical settings, targeting harmful bacteria with high specificity.

The startup develops lipid-based therapies targeting neuropathic pain in spinal cord injury patients and other neurological disorders. Its biotechnology platform simplifies treatment options for individuals suffering from various neurological conditions.

Aperture Therapeutics develops oligonucleotide therapeutics by identifying naturally occurring gene variants that confer protection against neurodegenerative diseases. The platform uses machine learning to analyze genomic and clinical datasets to prioritize protective gene variants for therapeutic mimicry. This approach targets genetically validated pathways to address shared drivers in ALS and FTD, expanding patient applicability beyond rare mutations.